Kari Ward, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-2319 Fax: 515-282-3234 |
Josie Michelle Rutherford, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3714 Ingersoll Ave, Des Moines, IA 50312 Phone: 515-309-6011 |
Khara J Keegan, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3714 Ingersoll Ave, Des Moines, IA 50312 Phone: 515-309-6011 Fax: 515-309-6014 |
Mary Elizabeth Winters, CNM, ARNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3509 E 29th St, Des Moines, IA 50317 Phone: 515-248-1600 Fax: 515-248-1610 |
Jamie Pinter, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 330 Laurel St Ste 2300, Des Moines, IA 50314 Phone: 515-643-6869 Fax: 515-643-6899 |
Lori A Steinmann, ARNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 330 Laurel St, Suite 2300, Des Moines, IA 50314 Phone: 515-643-6869 Fax: 515-643-6899 |
Sea A Fey, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1440 Pleasant St, Suite 1, Des Moines, IA 50314 Phone: 515-309-6011 Fax: 515-309-6014 |
News Archive
NextBio today announced the latest evolution of its innovative life science research platform, adding new capabilities for the integration and mining of high-throughput array and next-generation sequencing data. The new NextBio Sequence-Centric module enables researchers to effectively explore and utilize massive amounts of public and internally generated sequencing data, while allowing organizations to create corporate-wide genomic data platforms to serve the needs of their global research teams.
A team of researchers in Ecuador and the U.K. found that high altitudes may be linked to improved COVID-19 survival – particularly among patients with no comorbidities.
New research has shed light on the reasons driving doctors out of General Practice, following earlier findings that around two out of every five GPs in the South West are planning to leave direct patient care in the next five years.
The historic gap in suicide-related rates between Black and White youth is narrowing, according to a report released today by a Congressional taskforce.
pSivida Corp, a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today reported the interim 18-month safety and efficacy results from the first human pharmacokinetic study (PK Study) of Iluvien®. The PK trial is being conducted by Alimera Sciences, the licensee for Iluvien.
› Verified 8 days ago